TGTX

TG Therapeutics
TGTX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$5.74B
EV
$5.68B
Shares Outstanding
149.01M
Beta
2.14

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$43.00
P/E 2025E
37.97x
P/Revenue 2025E
10.36x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About TG Therapeutics, Inc.

gainify
TGTX

TG Therapeutics, Inc.

TGTX

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal ...

Sector

Healthcare

Industry

Biotechnology

CEO

Weiss, Michael

Employees

338

IPO Date

2010-05-03

Headquarters

3020 Carrington Mill Blvd., Suite 475, Morrisville, North Carolina, 27560, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved